ERLOTINIB IN NON-SMALL CELL LUNG CANCER: ANALYSIS OF TOXICITY AND EFFICACY IN CLINICAL PRACTICE

被引：0
|
作者：
Alexandre, Maria Teresa A. [1 ]
Ip, Joana [1 ]
Duarte, Isabel [1 ]
Almodovar, Teresa [1 ]
Da Costa, Jose Duro [1 ]
机构：
[1] Inst Portugues Oncol Lisboa, Lisbon, Portugal
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Lung cancer; Erlotinib; toxicity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.24-054
引用
收藏
页码：S1326 / S1327
页数：2
相关论文
共 50 条
  • [1] Retrospective Analysis of Clinical Efficacy of Erlotinib in Patients with Non-Small Cell Lung Cancer
    Ayyildiz, Aylin
    Kanat, Ozkan
    Ozkaya, Guven
    Deligonul, Adem
    Gursoy, Vildan
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2015, 6 (02) : 212 - 215
  • [2] Gefitinib and Erlotinib in Metastatic Non-Small Cell Lung Cancer: A Meta-Analysis of Toxicity and Efficacy of Randomized Clinical Trials
    Burotto, Mauricio
    Manasanch, Elisabet E.
    Wilkerson, Julia
    Fojo, Tito
    ONCOLOGIST, 2015, 20 (04): : 400 - 410
  • [3] Erlotinib in routine clinical practice in elderly patients with non-small cell lung cancer (ELDERTAC)
    Brueckl, W.
    Achenbach, H. J.
    Maintz, C.
    Schuette, W.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S606 - S606
  • [4] Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer
    Zhou, Songwen
    Ren, Shengxiang
    Yan, Lianghua
    Zhang, Ling
    Tang, Liang
    Zhang, Jie
    Zhou, Caicun
    RESPIROLOGY, 2009, 14 (05) : 709 - 715
  • [5] Efficacy and Toxicity of Erlotinib and Gefitinib in Moroccan Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutation
    Benchakroun, N.
    Minoungou, N.
    Bouchbika, Z.
    Jouhadi, H.
    Tawfik, N.
    Sahraoui, S.
    Benider, A.
    Acharki, A.
    Lemzah, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S953 - S953
  • [6] Erlotinib in non-small cell lung cancer: a review
    Blackhall, FH
    Rehman, S
    Thatcher, N
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) : 995 - 1002
  • [7] Clinical Efficacy of Erlotinib Combined with Probiotic Intervention in Treating Advanced Non-Small Cell Lung Cancer
    Ye, Qing
    Huang, Yan
    Lin, Jian
    Ye, Lingyan
    Xu, Youzu
    Chen, Meifang
    Gong, Liuyang
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2024, 22 (02) : 575 - 581
  • [8] Erlotinib in the treatment of non-small cell lung cancer
    Brown, Ewan R.
    Shepherd, Frances A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (05) : 767 - 775
  • [9] Efficacy and clinical/molecular predictors of erlotinib monotherapy for Chinese advanced non-small cell lung cancer
    Zhu Yu-jia
    Xia Ying
    Ren Guan-jun
    Wang Meng-zhao
    Zeng Xuan
    Zhang Li
    CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3200 - 3205
  • [10] Cutaneous toxicity in erlotinib treatment for advanced non-small cell lung cancer (NSCLC)
    Bernabee, R.
    Cobo, M.
    Barneto, I.
    Valdivia, J.
    Fernandez, I.
    Rueda, A.
    Villatoro, R.
    de la Curz, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345